Skip to main content
TipRanks
Go Ultimate75% OFF

Green Thumb Industries (GTII) AI Stock Analysis

251 Followers
TSE:GTII

Green Thumb Industries

(CNQX:GTII)

Select Model
Rating:69Neutral
Price Target:CAD 10.00▲(15.74% Upside)
Action:reiterated
Date:11/06/26

The score is led by solid financial fundamentals (profitability, manageable leverage, and strong operating/free cash flow) and a relatively modest P/E valuation. These positives are tempered by weaker technical momentum (below key moving averages with negative MACD) and earnings-call risks centered on continued pricing pressure, near-term revenue softness, and regulatory/tax uncertainty.

Positive Factors
Revenue Growth and ProfitabilityStrong top-line growth combined with positive gross and net margins indicates meaningful operating scale and established demand for the company’s products. Although margins have eased, the business remains profitable while expanding, supporting continued investment in stores, brands, and production capacity.
Negative Factors
Pricing Pressure and Margin CompressionPersistent price compression and competition can reduce the profit captured from each unit sold, making revenue growth less valuable and limiting operating leverage. If these conditions continue across state markets, they may keep gross margins below prior peaks and pressure cash generation.

Green Thumb Industries (GTII) vs. iShares MSCI Canada ETF (EWC)

-20%0%20%40%60%80%TSE:GTII+16.76%EWC+17.53%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Market Cap
CAD 1.32B
Dividend Yield
―
Average Volume (3M)
154.64K
Price to Earnings (P/E)
14.2
Beta (1Y)
1.19
Revenue Growth
6.44%
EPS Growth
127.50%
Country
Canada
Employees
5,000
Sector
Healthcare
Sector Strength
51
Industry
Drug Manufacturers - Specialty & Generic

Green Thumb Industries Business Overview & Revenue Model

Company Description

Green Thumb Industries Inc. is a U.S.-based company focused on the cultivation, processing, and distribution of cannabis products for both medicinal and adult recreational consumption. Its diverse product portfolio includes raw cannabis flower and a...

How the Company Makes Money

GTII primarily makes money by selling cannabis and cannabis-derived products through two main channels: (1) retail sales through company-owned dispensaries and (2) wholesale sales of branded products to other dispensaries and retail operators. In ret...

Green Thumb Industries Earnings Call Summary

Earnings Call Date:Nov 04, 2026(Q3-2026)|% Change Since:-5.37%|Next Earnings Date:May 30, 2019
Earnings Call SentimentPositive

The call was predominantly positive: Green Thumb delivered double-digit revenue growth, positive same-store sales, higher normalized EBITDA, strong operating cash flow, brand leadership, and continued expansion supported by a substantial cash balance. However, management emphasized persistent pricing pressure, a stressed consumer, lower reported gross margin, higher operating costs, a GAAP net loss, uncertain federal and hemp policy, and possible continued tax liabilities. The positive operating performance and strategic positioning outweighed the stated challenges.

Positive Updates

Revenue and Normalized EBITDA Growth
Third-quarter revenue was $324 million, up 11% year-over-year and approximately 6% sequentially from the second quarter. Normalized EBITDA was $89.4 million, or 27.6% of revenue, compared with $80.2 million, or 27.5%, in the prior-year period.

Negative Updates

Federal Regulatory Uncertainty
Medical cannabis is on Schedule III, but the broader federal rescheduling decision remains pending. Management described the federal landscape as the industry's single biggest wild card and said institutional investors still need certainty on federal scheduling and taxes.

Company Guidance

Green Thumb expects full-year 2026 CapEx of approximately $80 million, excluding real estate purchases; fourth quarter sequential revenue is expected to be flat to down slightly due to the pricing environment, with some continued compression expected in the coming quarters. The company expects to open anywhere between three and five additional stores in Florida between now and the end of the year, and over the next 12 to 16 months anticipates 10 plus stores in Florida and one or two in Ohio, while Texas remains the big unknown. Virginia adult-use sales are scheduled to begin July 1st, 2027, and the company’s guess is that it could take anywhere from 12 to 24 to maybe 36 months before there is enough capacity in the state to absorb the potential demand.

Green Thumb Industries Financial Statement Overview

Summary

Strong TTM revenue growth (~273%) with healthy profitability (gross margin ~44.9%, net margin ~10.6%) and meaningful positive operating cash flow (~$253M) and free cash flow (~$180M). Offsetting this, margins have compressed versus prior peaks (EBIT margin down vs 2024) and free cash flow declined versus 2025 with a history of volatility, while returns remain mid-single-digit (ROE ~6.8%).

Income Statement

78Positive

Balance Sheet

74Positive

Cash Flow

70Positive
Financial statement breakdown
BreakdownTTMDec 2025Dec 2024Dec 2023Dec 2022Dec 2021
Income Statement
Total Revenue1.24B1.20B1.14B1.05B1.02B893.56M
Gross Profit545.47M548.94M601.11M526.50M503.96M491.93M
EBITDA319.12M337.13M392.00M324.14M270.28M329.53M
Net Income99.68M116.15M73.08M36.27M11.98M75.44M
Balance Sheet
Total Assets2.85B2.78B2.54B2.49B2.43B2.39B
Cash, Cash Equivalents and Short-Term Investments316.00M284.76M171.69M161.63M177.68M230.42M
Total Debt554.50M518.35M530.70M570.28M535.86M431.69M
Total Liabilities986.36M877.81M747.93M786.80M768.10M766.37M
Stockholders Equity1.86B1.90B1.79B1.70B1.67B1.62B
Cash Flow
Free Cash Flow179.51M217.60M115.00M4.93M-20.94M-55.80M
Operating Cash Flow253.40M300.09M195.18M224.97M158.56M132.05M
Investing Cash Flow-92.81M-132.67M-89.54M-227.91M-219.95M-280.73M
Financing Cash Flow-80.17M-51.83M-95.59M-13.11M8.64M295.34M

Green Thumb Industries Technical Analysis

Technical Analysis SentimentNegative
Last Price8.64

Price Trends

50DMA9.62Negative
100DMA9.92Negative
200DMA9.87Negative

Market Momentum

MACD-0.16Negative
RSI41.89Neutral
STOCH10.90Positive

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For TSE:GTII, the sentiment is Negative. The current price of 8.64 is below the 20-day moving average (MA) of 9.03, below the 50-day MA of 9.62, and below the 200-day MA of 9.87, indicating a bearish trend. The MACD of -0.16 indicates Negative momentum. The RSI at 41.89 is Neutral, neither overbought nor oversold. The STOCH value of 10.90 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for TSE:GTII.

Green Thumb Industries Risk Analysis

Green Thumb Industries disclosed 67 risk factors in its most recent earnings report. Green Thumb Industries reported the most risks in the "Finance & Corporate" category.

Higher RiskSector Avg.Lower RiskFinance & CorporateTech & InnovationLegal & RegulatoryProductionAbility to SellMacro & Political
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy

Latest Risks Added

3 New Risks
1.Psychoactive hemp-based products are federally illegal if they exceed the limits of the Farm Bill.Q4, 2023
2.We may be required to disclose personal information of our owners, investors, officers, managers, and directors to regulators and failure to do so could endanger our ability to expand, endanger our licenses, or cause the Company to incur costs to redeem securities held by uncooperative shareholders.Q4, 2023
3.We rely on the expertise of our management team and other employees experienced in the cannabis industry, and the loss of key personnel could negatively affect our business, financial condition and results of operations.Q4, 2023

Green Thumb Industries Peers Comparison

Overall Rating

UnderperformOutperform
Sector (51)

Financial Indicators

TSE:GTII against its peers
NameOverall RatingMarket CapP/E RatioROEDividend YieldRevenue GrowthEPS Growth
TSE:GTIITSE:GTII69NeutralCAD 1.89B14.175.30%―6.44%127.50%
TSE:CURATSE:CURA52NeutralCAD 3.07B-223.82-1.47%―5.01%92.12%
Sector *51Neutral$7.86B-0.30-43.30%2.27%22.53%-2.21%
TSE:VRNOTSE:VRNO51NeutralCAD 2.17B-1.31-30.11%―0.61%37.92%
TSE:JUSHTSE:JUSH49NeutralCAD 109.84M-1.4040.14%―5.37%17.78%
TSE:CLTSE:CL45NeutralCAD 328.01M-1.75-28.54%―-2.43%-80.34%

* Healthcare Sector Average

Performance Comparison

0%50%100%150%TSE:GTIITSE:JUSHTSE:CURATSE:CLTSE:VRNODec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
TSE:GTII and its peers over the selected period
Show on chartTickerCompany NamePriceChange% Change
TSE:GTIIGreen Thumb Industries (OTC)8.641.1114.74%
TSE:JUSHJushi Holdings Inc0.550.000.00%
TSE:CURACuraleaf Holdings (Otc)11.413.3441.39%
TSE:CLCresco Labs OTC0.71-0.28-28.28%
TSE:VRNOVerano Holdings Corp.6.320.000.00%

Green Thumb Industries Corporate Events

Business Operations and StrategyStock Buyback

Green Thumb Extends $50 Million Share Buyback in Cannabis Market Confidence Play

Positive
Sep 21, 2026

Green Thumb Industries has authorized the continuation of its share repurchase program for another 12 months, allowing up to $50 million in subordinate voting share buybacks. The cannabis CPG and retail operator previously repurchased about 29.5 mill...

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Date of analysis: Nov 06, 2026